Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
06/2005
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1112263B1 Polymerizable polyalkoxylated naphthopyrans
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005CN1205200C Method for continuously acylating chromanol ester derivatives
06/08/2005CN1205171C Method for preparing 2-halomethyl phenylacetiate
06/07/2005US6903227 Synthesis of 2-acyl substituted chromanes and intermediates thereof
06/07/2005US6903226 Comprises xanthene-containing zinc complexes; for diagnosis of Alzheimer's disease
06/07/2005US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions
06/07/2005US6903097 Heterocycle carboxamides as antiviral agents
06/07/2005US6903084 Steroid sulphatase inhibitors
06/02/2005WO2005049562A2 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
06/02/2005WO2005049009A1 Methods and agents for inhibiting dynamin-dependent endocytosis
06/02/2005WO2005035491A3 PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND
06/02/2005WO2004103986A3 3-desoxyanthocyanidine compounds and uses thereof as antimicrobial agents
06/02/2005US20050119336 Synthesis of derivatives of ginkgolide C
06/02/2005US20050119334 Neurodegenerative disease; Alzheimer's and Parkinson's disease
06/02/2005US20050119269 Heterocyclic compounds and methods of making and using thereof
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005CA2556801A1 Methods and agents for inhibiting dynamin-dependent endocytosis
06/01/2005EP1535980A1 Photochromic composition
06/01/2005EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
06/01/2005EP1535918A1 Process for producing aminobenzopyran compound
06/01/2005EP1535612A1 Treatment for hyperuricemia
06/01/2005EP1534698A1 Flavonoid compounds as therapeutic antioxidants
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534660A1 Ketocampholenic acid derivatives and their use in fragrance and flavor applications
06/01/2005EP1534276A2 Non-nucleoside reverse transcriptase inhibitors
06/01/2005EP1534266A2 Color-stable, low impurity tocopherol compositions and processes for preparing the same
06/01/2005EP1534074A2 Combination therapy for the treatment of obesity
06/01/2005EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
06/01/2005EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
06/01/2005CN1622989A Fragrance compound
06/01/2005CN1622944A Method for producing 2-[-5-(4-fluoprophenyl)-3-pyridylmethylaminomethyl]-chromane
06/01/2005CN1622943A Heterocycle-bearing onium salts
06/01/2005CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
06/01/2005CN1204134C Sulfamine-substituted benzodihydopyran, preparation method, use as medicine or diagnostic reagent and medicine containing same
06/01/2005CN1203852C Valdecoxib compositions
05/2005
05/31/2005US6900340 Alcoholysis of ketene, forming ester; then hydrolysis
05/31/2005US6900241 Compositions for, and methods of, treating atherosclerosis
05/31/2005US6900240 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids.
05/26/2005WO2005047526A2 Method for identifying inhibitors using a homology model of polo-like kinase 1
05/26/2005WO2005047277A1 Photochromic fused pyrans substituted with phenyl carrying a carbamyl or urea group
05/26/2005WO2005047245A2 Fluorescence assays with improved blocking groups
05/26/2005WO2005047242A2 Compounds containing thiosulfate moieties
05/26/2005US20050113584 On solid support (polyamide) via condensation and dehydration; chromatography
05/26/2005US20050113444 Mixing a methyl-, ethyl-, or hydroxypropyl methyl cellulose binder with tocopheryl succinate spraying a liquid onto mixture in a granulator; drying
05/26/2005US20050113440 Compounds that modulate PPAR activity and methods for their preparation
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050112781 4,7-dichlororhodamine dyes labeled polynucleotides
05/25/2005EP1533309A1 Method of producing a tocopherol product
05/25/2005DE10348257A1 Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten A process for preparing enantiomereneinen in 2-substituted chroman derivatives
05/25/2005CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators
05/25/2005CN1620447A Isochroman compounds for treatment of cns disorders
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1203068C Extraction and purification method of licoflavone
05/25/2005CN1203067C Process for extracting lotus leaf flavone
05/25/2005CN1202818C Method for producing extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and cannabis extracts
05/24/2005US6897220 Antiproliferative agents
05/24/2005CA2157289C Photochromic naphthopyran compounds
05/19/2005WO2005044813A1 Benzopyrone compounds, preparation method and use thereof
05/19/2005WO2005044775A1 Process for the preparation of 2,3,5-trimethylhydroquinone diacylates
05/19/2005WO2005021496A3 Synthesis of derivatives of ginkgolide c
05/19/2005WO2004085568A3 Photochromic articles with reduced temperature dependency and methods for preparation
05/19/2005WO2004072254A3 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
05/19/2005US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors
05/19/2005US20050107431 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2005US20050107427 Benzyl urea and thiourea derivatives
05/19/2005DE10348298A1 Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation containing these compounds and pharmaceutical
05/19/2005CA2551056A1 Benzo[b][1,4]dioxepine derivatives
05/18/2005CN1617711A Liposomal delivery of vitamin E based compounds
05/18/2005CN1616448A Benzopyrone compounds with pest killing and sterilizing activity and preparation and use
05/18/2005CN1616447A Method for extracting wild apple flavone
05/18/2005CN1616381A Process for preparing Erigeron breviscapus active component
05/18/2005CN1202105C Low temperature proanthocyanidin extracting process from grape seed
05/18/2005CN1202058C New process of preparing tea polyphenol with high catechin content and low caffine content
05/18/2005CN1201730C Treatment of emphysema using RAR selective retinoid agonists
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2005042712A2 Heterocyclic compounds and methods of making and using thereof
05/12/2005WO2005042697A2 Compounds, compositions and methods
05/12/2005WO2005042539A1 Tocopherol-modified therapeutic drug compounds
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042510A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles
05/12/2005WO2005042509A1 7-`(7-alkoxy)-chrom-3-en-6-yl!-heptatrienoic acid and 7-`(3­alkoxy)-5,6-dihydronaphthalen-2-yl!-heptatrienoic acid derivatives modulators
05/12/2005WO2005042508A1 PLANT-ORIGIN β3-ADRENOCEPTOR AGONIST AND USE OF THE SAME
05/12/2005WO2005029189A8 Compound for resist and radiation-sensitive composition
05/12/2005US20050101662 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; cancer, Alzheimer's disease, gout, atherosclerosis, restenosis
05/12/2005US20050101546 Increased solubility flavanolignan preparations
05/12/2005CA2544781A1 Plant-derived .beta.3-adrenergic receptor agonist substances and uses thereof
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2540460A1 Heterocyclic compounds and methods of making and using thereof
05/12/2005CA2539817A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles
05/11/2005EP1529780A1 Photochromic fused pyrans substitued with phenyl carrying a carbamyl or urea group
05/11/2005CN1615305A Coumarin derivatives, process for their production and use thereof
05/11/2005CN1613855A Removal of caffeine from polyhydric phenol by supercritical carbon dioxide process
05/11/2005CN1613854A Extraction of oligomeric anthocyanin from pine bark
05/11/2005CN1200937C Acidylation method
05/11/2005CN1200916C Preparation method of total saponin and flavone extract in notoginseng leaf
05/10/2005US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal